Biogen Submits Response to the Centers for Medicare and Medicaid Services (CMS) Proposed National Coverage Determination (NCD) for Anti-Amyloid Treatments in Alzheimer’s Disease
Biogen Submits Response to the Centers for Medicare and Medicaid Services (CMS) Proposed National Coverage Determination (NCD) for Anti-Amyloid Treatments in Alzheimer’s Disease
February 10, 2022
• Company Statements
June 1, 2023
Biogen Announces Webcast of Annual Meeting of Stockholders
Cambridge, Mass. – June 1, 2023 – Biogen Inc. (Nasdaq: BIIB) announced today that the webcast of the Company's 2023 Annual Meeting of Stockholders will be held on Wednesday, June 14, 2023, at 9:00 a.m. Eastern Time. A live audio webcast of the meeting will be available on the Investor Relations
May 23, 2023
Biogen to Participate in the Jefferies Healthcare Conference
Cambridge, MA, - - Biogen Inc. (Nasdaq: BIIB) announced today that Michael McDonnell, Chief Financial Officer, and Priya Singhal, M.D., M.P.H., Head of Development, will participate in the Jefferies Healthcare Conference. The webcast will be live on Wednesday, June 7, 2023, at 11:30 a.m.